These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1465580)

  • 21. Neutralization of bacterial lipopolysaccharides by human plasma.
    Warren HS; Novitsky TJ; Ketchum PA; Roslansky PF; Kania S; Siber GR
    J Clin Microbiol; 1985 Oct; 22(4):590-5. PubMed ID: 3908471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
    Martínez-Martínez L; Fernández F; Perea EJ
    J Antimicrob Chemother; 1999 Feb; 43(2):277-9. PubMed ID: 11252335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between Escherichia coli growth rate and bacterial susceptibility to ciprofloxacin.
    Smirnova GV; Oktyabrsky ON
    FEMS Microbiol Lett; 2018 Jan; 365(1):. PubMed ID: 29228224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].
    Cokça F; Altay G
    Mikrobiyol Bul; 1992 Oct; 26(4):333-7. PubMed ID: 1435363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the ability of colistin, amoxicillin (components of Potencil
    Szuster-Ciesielska A; Urban-Chmiel R; Wernicki A; Mascaron L; Wasak M; Bousquet E
    J Vet Pharmacol Ther; 2019 Jan; 42(1):85-103. PubMed ID: 30218443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid assessment of ceftazidime, ciprofloxacin, and gentamicin susceptibility in exponentially-growing E. coli cells by means of flow cytometry.
    Walberg M; Gaustad P; Steen HB
    Cytometry; 1997 Feb; 27(2):169-78. PubMed ID: 9012384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
    Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Chemically-Induced Bacterial Ghosts (BGs) Using Sodium Hydroxide-Induced Vibrio parahaemolyticus Ghosts (VPGs).
    Park HJ; Oh S; Vinod N; Ji S; Noh HB; Koo JM; Lee SH; Kim SC; Lee KS; Choi CW
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum.
    Demonty J; De Graeve J
    Med Microbiol Immunol; 1982; 170(4):265-77. PubMed ID: 7048047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of sample processing for the Limulus amebocyte lysate assay enhances detection of inflammogenic endotoxin in intact bacteria and organic dust.
    Hoppe Parr KA; Hađina S; Kilburg-Basnyat B; Wang Y; Chavez D; Thorne PS; Weiss JP
    Innate Immun; 2017 Apr; 23(3):307-318. PubMed ID: 28359219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A re-appraisal of the biological activity of bacteroides LPS.
    Delahooke DM; Barclay GR; Poxton IR
    J Med Microbiol; 1995 Feb; 42(2):102-12. PubMed ID: 7869345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfiltration method of removal of bacterial contaminants and their monitoring by nitric oxide and Limulus assays.
    Zídek Z; Kmoníčková E; Kostecká P; Jansa P
    Nitric Oxide; 2013 Jan; 28():1-7. PubMed ID: 22981390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limulus amebocyte lysate test for endotoxemia: investigations with a femtogram sensitive spectrophotometric assay.
    Fink PC; Lehr L; Urbaschek RM; Kozak J
    Klin Wochenschr; 1981 Mar; 59(5):213-8. PubMed ID: 7012435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of anti-lipopolysaccharide antibodies to Vibrio cholerae O1 and O139 using a novel microtiter limulus amebocyte lysate (LAL) assay.
    Chang HS; Sack DA
    Clin Chim Acta; 2001 Oct; 312(1-2):49-54. PubMed ID: 11580909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of LAL for detection of endotoxin in antibiotic preparations.
    Harrison SJ; Tsuji K; Enzinger RM
    Prog Clin Biol Res; 1979; 29():353-65. PubMed ID: 388463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.